Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK Profile”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06190340
What this trial is testing

Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjects

Who this might be right for
Helicobacter Pylori Infection
TenNor Therapeutics (Suzhou) Limited 40
Early research (Phase 1)Study completedNCT02720224
What this trial is testing

Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol

Who this might be right for
ContraceptionMenopause
Estetra 6
Early research (Phase 1)Study completedNCT03714685
What this trial is testing

Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations

Who this might be right for
Healthy Males
Quantum Genomics SA 12
Post-approval studies (Phase 4)Study completedNCT00700115
What this trial is testing

Kaletra-isentress Treatment Evaluation

Who this might be right for
HIV Infections
Emory University 60
Early research (Phase 1)Study completedNCT03173573
What this trial is testing

Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants

Who this might be right for
Cystic Fibrosis
Flatley Discovery Lab LLC 109
Testing effectiveness (Phase 2)Study completedNCT03051256
What this trial is testing

Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD

Who this might be right for
Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant
Relmada Therapeutics, Inc. 62
Early research (Phase 1)UnknownNCT06149988
What this trial is testing

Comparative PK Study Of THC/CBD Formulations

Who this might be right for
Cannabis
CapSoil 14
Post-approval studies (Phase 4)Looking for participantsNCT07174830
What this trial is testing

Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese Participants

Who this might be right for
Healthy Participants
Shenzhen Salubris Pharmaceuticals Co., Ltd. 54
Early research (Phase 1)Study completedNCT03424252
What this trial is testing

Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Flatley Discovery Lab LLC 11
Early research (Phase 1)Study completedNCT01925521
What this trial is testing

OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.

Who this might be right for
Healthy
Korea Otsuka Pharmaceutical Co., Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT01652885
What this trial is testing

Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 23
Early research (Phase 1)Looking for participantsNCT06756451
What this trial is testing

This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.

Who this might be right for
Hematologic Malignancies
Nanjing RegeneCore Biotech Co., Ltd. 71
Early research (Phase 1)Not Yet RecruitingNCT07462455
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Xiamen Amoytop Biotech Co., Ltd. 24
Early research (Phase 1)Ended earlyNCT02688790
What this trial is testing

Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

Who this might be right for
Bacterial Infections
AbbVie 8
Early research (Phase 1)Study completedNCT00679835
What this trial is testing

PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections

Who this might be right for
Gram Positive InfectionConcurrent Antibiotic Treatment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Early research (Phase 1)Study completedNCT00698464
What this trial is testing

Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function

Who this might be right for
Hepatic CirrhosisAlcoholism
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT06542614
What this trial is testing

Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 209
Early research (Phase 1)Study completedNCT03830463
What this trial is testing

Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers

Who this might be right for
Healthy
Concert Pharmaceuticals 42
Not applicableStudy completedNCT01260675
What this trial is testing

Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone

Who this might be right for
Healthy
NanoSHIFT LLC 12
Testing effectiveness (Phase 2)Study completedNCT06973681
What this trial is testing

BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

Who this might be right for
Overweight or Obesity
BrightGene Bio-Medical Technology Co., Ltd. 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation